Yuichi Saito

Prof. Dr. Yuichi Saito

Teikyo University, Tokyo, Japan
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
Yuichi SaitoYuichi Saito
Yuichi Saito
YKYasuyuki Kawai
Yasuyuki Kawai
NTNobumasa Takahashi
Nobumasa Takahashi
TITomohiko Ikeya
Tomohiko Ikeya
KMKatsumi Murai
Katsumi Murai
EHEishin Hoshi
Eishin Hoshi

1 December 2019 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
Yuichi SaitoYuichi Saito
Yuichi Saito
SHSho Horiuchi
Sho Horiuchi
HMHiroaki Morooka
Hiroaki Morooka
TITakayuki Ibi
Takayuki Ibi
NTNobumasa Takahashi
Nobumasa Takahashi
EHEishin Hoshi
Eishin Hoshi
Background: The Dako PD-L1 immunohistochemistry (IHC) 22C3 pharmDx and the Dako 28-8 IHC pharmDx assays were approved by the US Food and Drug Administration, as a companion diagnostic test for pembrolizumab (Keytruda, Merk, Kenilworth, NJ, USA) and a complementary diagnostic test for nivolumab (Opdivo, Bristol Meyer Squibb, New York, NY, USA) in non-small cell lung cancer (NSCLC), respectively. Increased PD-L1 expression levels can be associated with greater therapeutic efficacy of pembrolizumab relative to other anti-PD-1 agents. However, in treatment decision making, little is known about which tissue (primary or metastatic lesion) should be stained by 22C3 antibody. We investigated the relationship between PD-L1 expression in primary tumors and paired metastatic lymph nodes using the 22C3 assay, and evaluated the concordance between the 22C3 and 28-8 assays. Methods: PD-L1 expression was evaluated in cells from primary tumors and paired metastatic lymph nodes using the 22C3 and 28-8 IHC assays. Total 35 patients with primary tumor and paired metastatic lymph node were enrolled into this study, and all samples were surgically resected, formalin-fixed, and paraffin-embedded NSCLC tissues. Tumor cells exhibiting complete or partial membrane staining, were considered as PD-L1 positive. On the basis of tumor proportion score (TPS), all samples were classified as no expression (TPS: <1%), low expression (TPS: 1–49%), or high expression (TPS: ≥50%). Results: TPS distribution was markedly different between primary tumors and paired metastatic lymph nodes. In 22C3 IHC assay, TPS similar to that of metastatic lymph nodes was demonstrated in 10 primary tumors, and concordance rate between them was 28.6%. Concurrently, in 28-8 IHC assay, 11 primary tumors had TPS similar to that of metastatic lymph nodes, with a concordance rate of 31.4%. Conclusions: TPS concordance rates (for both 22C3 and 28-8 antibodies) between primary tumors and paired lymph nodes were low. Inter-tumor heterogeneity of PD-L1 expression is an important issue for clinical oncologists during treatment planning.

23 April 2020 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
BCBenjamin R Challoner
Benjamin R Challoner
KLKatharina von Loga
Katharina von Loga
AWAndrew Woolston
Andrew Woolston
BGBeatrice Griffiths
Beatrice Griffiths
NSNanna Sivamanoharan
Nanna Sivamanoharan
MGMarco Gerlinger
Marco Gerlinger
Gastric and gastro-esophageal junction cancers (GCs) frequently recur after resection, but markers to predict recurrence risk are missing. T-cell infiltrates have been validated as prognostic markers in other cancer types, but not in GC because of methodological limitations of past studies. We aimed to define and validate the prognostic role of major T-cell subtypes in GC by objective computational quantification. Surgically resected chemotherapy-naïve GCs were split into discovery (n = 327) and validation (n = 147) cohorts. CD8 (cytotoxic), CD45RO (memory), and FOXP3 (regulatory) T-cell densities were measured through multicolor immunofluorescence and computational image analysis. Cancer-specific survival (CSS) was assessed. All statistical tests were two-sided. CD45RO-cell and FOXP3-cell densities statistically significantly predicted CSS in both cohorts. Stage, CD45RO-cell, and FOXP3-cell densities were independent predictors of CSS in multivariable analysis; mismatch repair (MMR) and Epstein–Barr virus (EBV) status were not statistically significant. Combining CD45RO-cell and FOXP3-cell densities into the Stomach Cancer Immune Score showed highly statistically significant (all P ≤ .002) CSS differences (0.9 years median CSS to not reached). T-cell infiltrates were highest in EBV-positive GCs and similar in MMR-deficient and MMR-proficient GCs. The validation of CD45RO-cell and FOXP3-cell densities as prognostic markers in GC may guide personalized follow-up or (neo)adjuvant treatment strategies. Only those 20% of GCs with the highest T-cell infiltrates showed particularly good CSS, suggesting that a small subgroup of GCs is highly immunogenic. The potential for T-cell densities to predict immunotherapy responses should be assessed. The association of high FOXP3-cell densities with longer CSS warrants studies into the biology of regulatory T cells in GC.

7 January 2016 in Cancer Science
Verified
Journal Article
Open access
PDF file
Yuichi SaitoYuichi Saito
Yuichi Saito
GNGenta Nagae
Genta Nagae
NMNoriko Motoi
Noriko Motoi
EMEisaku Miyauchi
Eisaku Miyauchi
HNHironori Ninomiya
Hironori Ninomiya
YIYuichi Ishikawa
Yuichi Ishikawa
Methylation is closely involved in the development of various carcinomas. However, few datasets are available for small cell lung cancer (SCLC) due to the scarcity of fresh tumor samples. The aim of the present study is to clarify relationships between clinicopathological features and results of the comprehensive genome‐wide methylation profile of SCLC. We investigated the genome‐wide DNA methylation status of 28 tumor and 13 normal lung tissues, and gene expression profiling of 25 SCLC tissues. Following unsupervised hierarchical clustering and non‐negative matrix factorization, gene ontology analysis was performed. Clustering of SCLC led to the important identification of a CpG island methylator phenotype (CIMP) of the tumor, with a significantly poorer prognosis (P = 0.002). Multivariate analyses revealed that postoperative chemotherapy and non‐CIMP were significantly good prognostic factors. Ontology analyses suggested that the extrinsic apoptosis pathway was suppressed, including TNFRSF1A, TNFRSF10A and TRADD in CIMP tumors. Here we revealed that CIMP was an important prognostic factor for resected SCLC. Delineation of this phenotype may also be useful for the development of novel apoptosis‐related chemotherapeutic agents for treatment of the aggressive tumor.

1 March 2009 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
Yuichi SaitoYuichi Saito
Yuichi Saito
TITomohiko Ikeya
Tomohiko Ikeya
EHEishin Hoshi
Eishin Hoshi
NTNobumasa Takahashi
Nobumasa Takahashi
KMKatsumi Murai
Katsumi Murai
TCThomas V. Colby
Thomas V. Colby

26 January 2024 in Annals of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
TWTomohiro Watanabe
Tomohiro Watanabe
Yoshikane YamauchiYoshikane Yamauchi
Yoshikane Yamauchi
RTRyo Takeyama
Ryo Takeyama
SKShinya Kohmaru
Shinya Kohmaru
HDHitoshi Dejima
Hitoshi Dejima
YSYukinori Sakao
Yukinori Sakao
Purpose: A prolonged air leak (PAL) is one of the common postoperative complications of pulmonary resection. The aim of this study was to evaluate the efficacy and safety of pleurodesis with sterile talc or OK-432 for postoperative air leak.Methods: Patients with postoperative air leak who received chemical pleurodesis using sterile talc or OK-432 were retrospectively identified from medical records data. For pleurodesis with either agent, prior assessment and approval by the hospital safety department were carried out for each case, in addition to individual consent.Results: Between February 2016 and June 2022, 39 patients had PALs and underwent chemical pleurodesis. Among them, 24 patients received pleurodesis with talc (Talc group) and 15 with OK-432 (OK-432 group). The leak resolved after less than two pleurodesis treatments in 22 patients (91.7%) in the Talc group compared with 14 patients (93.3%) in the OK-432 group. Pleurodesis significantly increased white blood cell counts, C-reactive protein concentration, and body temperature in the OK-432 group compared with that in the Talc group (p <0.001, p = 0.003, and p <0.001, respectively).Conclusions: Pleurodesis with talc may be an effective treatment option for postoperative air leak. Our findings suggest that talc was as effective as OK-432 and resulted in a milder systemic inflammatory response.